Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

INTANGIBLE ASSETS, NET (Narrative) (Details)

v3.22.1
INTANGIBLE ASSETS, NET (Narrative) (Details) - CAD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Disclosure of subsidiaries [line items]    
Amortization expense $ 1,158 $ 31
Adjupharm GmbH ("Adjupharm") [Member]    
Disclosure of subsidiaries [line items]    
Pre-tax discount rate of cash flows 13.06%  
Fixed growth rate 3.00%  
Trichome Financial Corp. (“Trichome”) [Member]    
Disclosure of subsidiaries [line items]    
Pre-tax discount rate of cash flows 11.78%  
Fixed growth rate 4.00%